TY  - GEN
AU  - Blaise,Didier
AU  - Vey,Norbert
AU  - Faucher,Catherine
AU  - Mohty,Mohamad
TI  - Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia
SN  - 1592-8721
PY  - 2007///0809
KW  - Acute Disease
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antilymphocyte Serum
KW  - Antineoplastic Agents, Alkylating
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bone Marrow Diseases
KW  - chemically induced
KW  - Clinical Trials as Topic
KW  - statistics & numerical data
KW  - Combined Modality Therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Graft vs Leukemia Effect
KW  - Hematopoietic Stem Cell Transplantation
KW  - mortality
KW  - Humans
KW  - Leukemia, Myeloid
KW  - drug therapy
KW  - Lymphocyte Depletion
KW  - Male
KW  - Middle Aged
KW  - Recurrence
KW  - Remission Induction
KW  - Survival Analysis
KW  - T-Lymphocytes
KW  - Time Factors
KW  - Transplantation Conditioning
KW  - adverse effects
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Vidarabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.3324/haematol.10867
ER  -